The purpose of this paper was to compare the diagnostic adequacy and accuracy and the number of passes required to obtain adequate material between 22-gauge (G) and 25-G endoscopic-ultrasound (EUS)-guided fine needle aspiration (FNA) biopsies.
A prospective randomized study comparing 25-G and 22-G needles of a new platform for endoscopic ultrasound-guided fine needle aspiration of solid masses.
Carrara S, Anderloni A, Jovani M, Di Tommaso L, Rahal D, Hassan C, Ridola L, Federico D, Loriga A, Repici A
Purpose
Conclusion
Although biopsy using a 22-G needle was more likely to yield a core in addition to a smear; diagnostic accuracy was higher for 25-G needle biopsies than 22-G needle biopsies. However, no differences between 22-G or 25-G FNA specimens were observed in the percentage of specimens that were adequate, the average number of needle passes required, the percentage of specimens requiring rebiopsy, or the diagnostic accuracy after rebiopsy with the other needle type. Rebiopsy with the other needle type significantly increased the percentage of specimens with adequate material and diagnostic accuracy.
Studies (1)
Purpose
This study compared the diagnostic adequacy and accuracy and the number of passes required to obtain adequate material between 22-G and 25-G EUS-guided FNA biopsies. One hundred forty-four patients with solid pancreatic masses were randomized for biopsy with EUS-FNA using 22-G or 25-G needles (72 patients/group). For both needles, the aspiration was conducted using fanning and the slow pull method. Specimens were smeared on glass slides and evaluated immediately for adequacy of cellular material by a cytotechnician and bloody or “worm-like” material was fixed in formalin. Adequate material was not obtained in the first 3 passes for 14 specimens obtained using a 25-G biopsy needle and 12 specimens using a 22-G needle and rebiopsy was performed using the other needle size.
Summary of Findings
FFNA obtained with a 25-G needle was more likely to only yield a smear (rather than a smear and core) than FNA obtained using a 22-G needle (55.6% versus 37.5%, P=0.03). Further, diagnostic accuracy for neoplasia was higher for 25-G FNA specimens than 22-G FNA specimens (79% versus 64%, respectively; P=0.04). However, no differences between 22-G or 25-G FNA specimens were observed in the percentage of specimens that were adequate (68% versus 81%, respectively; P=0.09) or the average number of needle passes required (2.2, both). Rebiopsy using the other needle type was determined to be necessary in comparable percentages of patients (19% in 22-G group and 17% in 25-G group). Rebiopsy increased the overall percentage of specimens deemed adequate from 74% to 90% (P<0.01) and the overall diagnostic accuracy from 71% to 88.2% (P=0.04). After rebiopsy using the other needle type, the percentage of specimens with adequate material was higher for specimens initially biopsied with the 25-G needle than the 22-G needle (95.8% versus 86.1%, P=0.03), but there were no differences in mean number of passes required (3 versus 2.6, respectively) or diagnostic accuracy (91.7% versus 92.9%, respectively).
Biospecimens
CellPancreasCellLymph NodeTissuePancreasTissueLymph NodeTissueStomachTissueSmall BowelPreservation Types
FormalinNone (Fresh)Diagnoses
NeoplasticCarcinomaNeoplasticBenignNeoplasticNot specifiedNot specifiedPlatforms
MorphologyLight microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Needle gauge 22-G needle25-G needle